MedTrace Logo

REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)

NCT01574144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-12-30

Study results available
· View outcomes & findings →

Summary

The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF)

Changes in physiologic data are expected to correlate with 30-day readmission rates in this population

Conditions

  • Acute Decompensated Heart Failure

Interventions

DEVICE

AVIVO™ PiiX Patch Monitor System

External monitoring for 30 days post-discharge.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • READMIT-HF Study Team · Medtronic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-04-30
Completion
2013-08-31

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01574144 on ClinicalTrials.gov